Apgar score less than 7 at 5 minutes · Pregnant women with/without complications
It is very uncertain whether traditional antenatal CTG changes apgar less than 7 at 5 minutes compared with no antenatal CTG (women at increased risk of complication) (very low certainty).
1 finding from 1 review
Admission to neonatal special care unit or intensive care unit · Pregnant women with/without complications
Traditional antenatal CTG showed no clear difference in admission to neonatal special care unit or intensive care unit compared with no antenatal CTG (women at increased risk of complication) (low certainty).
1 finding from 1 review
Neurodevelopmental disability · Pregnant women with/without complications
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Caesarean section for non‐reassuring or abnormal fetal heart rate patterns · Pregnant women with/without complications
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Women's satisfaction with care · Pregnant women with/without complications
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Perinatal mortality · Pregnant women with/without complications
Computerised antenatal CTG probably leads to lower perinatal mortality compared with traditional antenatal CTG (women at increased risk of complications) (moderate certainty).
1 finding from 1 review
Caesarean section · Pregnant women with/without complications
Computerised antenatal CTG showed no clear difference in caesarean section compared with traditional antenatal CTG (women at increased risk of complications) (low certainty).
1 finding from 1 review
All‐cause mortality · people at increased risk for developing type 2 diabetes
It is very uncertain whether acarbose changes all‐cause mortality compared with placebo (very low certainty).
1 finding from 1 review
Serious adverse events · people at increased risk for developing type 2 diabetes
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cardiovascular mortality · people at increased risk for developing type 2 diabetes
It is very uncertain whether acarbose changes cardiovascular mortality compared with no intervention (very low certainty).
1 finding from 1 review
(1) Non‐fatal myocardial infarction (2) Non‐fatal stroke (3) Congestive heart failure · people at increased risk for developing type 2 diabetes
It is very uncertain whether acarbose changes (a)Non‐fatal myocardial infarction (b)Non‐fatal stroke (c)Congestive… compared with no intervention (very low certainty).
1 finding from 1 review
Health‐related quality of life · people at increased risk for developing type 2 diabetes
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Socioeconomic effects · people at increased risk for developing type 2 diabetes
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Development of type 2 diabetes · people at increased risk for developing type 2 diabetes
Acarbose probably leads to lower incidence of T2DM compared with placebo (moderate certainty).
1 finding from 1 review
Serious adverse events · people at increased risk for developing type 2 diabetes
Acarbose showed no clear difference in serious adverse events compared with placebo (low certainty).
1 finding from 1 review
Cardiovascular mortality · people at increased risk for developing type 2 diabetes
It is very uncertain whether acarbose changes cardiovascular mortality compared with placebo (very low certainty).
1 finding from 1 review
(1) Non‐fatal myocardial infarction (2) Non‐fatal stroke (3) Congestive heart failure · people at increased risk for developing type 2 diabetes
It is very uncertain whether acarbose changes (a)Non‐fatal myocardial infarction (b)Non‐fatal stroke (c)Congestive… compared with placebo (very low certainty).
1 finding from 1 review
Health‐related quality of life · people at increased risk for developing type 2 diabetes
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Socioeconomic effects · people at increased risk for developing type 2 diabetes
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality · people at increased risk for developing type 2 diabetes
1 finding from 1 review